ICON PLC (ICLR) vs RadNet, Inc. (RDNT)

ICON PLC and RadNet, Inc. are both Diagnostics & Research companies. ICON PLC is the larger, with a market value of $15.1B against $6.1B — 2.5× the size. RadNet, Inc. has negative trailing earnings, so its P/E is not meaningful; ICON PLC trades at 34.5×. RadNet, Inc. grew revenue faster over the last twelve months: 18.9% against 1.82%. ICON PLC has the higher net margin (5.45% vs −0.93%) and the higher return on invested capital (3.84% vs 2.24%). Across the 21 metrics below, ICON PLC leads on 17 and RadNet, Inc. on 4.

Valuation

Metric ICLR RDNT Diagnostics & Research median
P/E 34.48 n/m 34.52
P/S 1.88 2.69 4.24
P/B 1.70 4.38 3.42
Price to free cash flow 18.10 188.87 33.51
EV/EBITDA 17.86 21.80 23.44
EV/Sales 2.35 2.96 5.18
Earnings yield 2.90% (0.34%) (1.50%)
Free cash flow yield 5.53% 0.53% 0.00%

Profitability

Metric ICLR RDNT Diagnostics & Research median
Gross margin 23.43% 11.53% 48.32%
Operating margin 8.72% 3.12% (5.68%)
Net margin 5.45% (0.93%) (4.10%)
Free cash flow margin 10.41% 3.28% 0.00%
Return on equity 4.86% (1.64%) 0.00%
Return on assets 2.74% (0.55%) (6.05%)
Return on invested capital 3.84% 2.24% 0.00%

Growth

Metric ICLR RDNT Diagnostics & Research median
Revenue growth (TTM) 1.82% 18.92% 8.99%
EPS growth (last fiscal year) (67.42%) (725.00%) 20.36%
Revenue growth, 5-year CAGR 24.15% 13.74% 7.30%
Net income growth, 5-year CAGR (7.15%) 0.00% 0.00%

Health

Metric ICLR RDNT Diagnostics & Research median
Debt to equity 0.37 0.94 0.01
Current ratio 1.32 1.48 2.27
Net debt to EBITDA 3.34 1.16 0.68

Dividend

Metric ICLR RDNT Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric ICLR RDNT Diagnostics & Research median
Market cap 15.11b 6.14b 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack